List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. IGF OT IGF SYNTHESIS OF HIGH MANNOSE N GLYCANS

    SBC: OMICRON BIOCHEMICALS, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  2. IGF OT IGF Leveraging Mobile Biosensors for Just in time Intervetion

    SBC: Lumme Inc            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF PEAKS Validation of Mobile Technologies for Clinical Assessment Monitoring and Interventio

    SBC: EveryFit, Inc. (DBA "QMedic")            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF Phase II High Density RT PCR Arrays for Cancer Diagnosis and Prognosis

    SBC: PathRX Inc            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. IGF OT IGF SPADES A System for Encouraging Adoption of New Methods for Activity Monitoring

    SBC: EveryFit, Inc. (DBA "QMedic")            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. IGF OT IGF SBIR TOPIC PHASE II NOVEL BIOABSORBABLE FLEXIBLE POLYMERIC STENT FOR PEDIATRIC CARDIOLOGY

    SBC: 480 Biomedical Inc.            Topic: ODHLBI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. IGF OT IGF SBIR TOPIC DIRECT TO PHASE II CLOSURE DEVICES FOR TRANSCAVAL ACCESS TO THE ABDOMINAL AORTA

    SBC: TRANSMURAL SYSTEMS LLC            Topic: NHLBI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. IGF OT IGF SBIR PHASE II TOPIC STRATEGY FOR FINDING CASES OF MODERATE TO SEVERE COPD

    SBC: DIMAGI, INC.            Topic: DLD

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. IGF OT IGF MR CONTRAST AGENT TO QUANTIFY MYOCARDIAL FIBROSIS SBIR TOPIC PHASE II

    SBC: Collagen Medical, LLC            Topic: DHVD

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Novel commensal polysaccharide treats multiple sclerosis through Treg modulation

    SBC: SYMBIOTIX BIOTHERAPIES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Multiple sclerosis MS is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults affecting over patients in the US and over million patients worldwide MS is a disease of high unmet medical need currently treatable with one of twelve FDA approved drugs all of which result in either significant i ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government